Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group compar (Q33612741)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group compar |
scientific article |
Statements
1 reference
Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group compar (English)
1 reference
Kohei Kaku
1 reference
Hirotaka Watada
1 reference
Yasuhiko Iwamoto
1 reference
Kazunori Utsunomiya
1 reference
Yasuo Terauchi
1 reference
Kazuyuki Tobe
1 reference
Yukio Tanizawa
1 reference
Eiichi Araki
1 reference
Masamichi Ueda
1 reference
Hideki Suganami
1 reference
Daisuke Watanabe
1 reference
Tofogliflozin 003 Study Group
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference